<DOC>
	<DOCNO>NCT02982733</DOCNO>
	<brief_summary>In 2008 Goker et al , introduce Ankaferd Blood Stopper ( ABS ) new hemostatic drug . Recently , ABS show produce local hemostasis implement topically major arterial vessel injury . Reducing compression time patent hemostasis facilitate hemostasis may decrease RAO . To test hypothesis investigator plan three arm randomize study evaluate safety efficacy Ankaferd blood stopper adjunct short-time compression , compare either short-time compression conventional sterile gauze TR band transradial diagnostic procedure .</brief_summary>
	<brief_title>Ankaferd Blood Stopper Hemostasis After Transradial Coronary Angiography</brief_title>
	<detailed_description />
	<mesh_term>Hematoma</mesh_term>
	<criteria>All consecutive patient undergo transradial elective diagnostic coronary procedure November 2016 November 2017 catheterization laboratory Acibadem University Kocaeli Hospital consider enrol study . The exclusion criterion abnormal Barbeau 's test puncture failure provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>